Talk.Bio

🧵 Sanofi Discontinues mRNA Seasonal Flu Vaccine Development, Focuses on Existing Vaccines Amid CEO Confidence #SanofiMrnaFlu

1/ read more at talk.bio/2026/01/lilly-…

🧵 Lilly Invests $85M Upfront in Repertoire Immune Medicines for Autoimmune Therapies Partnership #EliLillyRepertoire

1/ read more at talk.bio/2026/01/astraz…

🧵 AstraZeneca Announces $15 Billion Investment in China Through 2030 #AstrazenecaChina15b

1/ read more at talk.bio/2026/01/tecreg…

🧵 TECregen Appoints Dr. Klaas P. Zuideveld as CEO to Lead Thymus Regeneration Platform #TecregenKlaasZuideveld

1/ read more at talk.bio/2026/01/friday…

🧵 Friday Five: Sanofi and Roche Face Headwinds Amid US Pricing Pressures and 2026 Drug Pipeline Shifts #SanofiRocheVaccines

1/ read more at talk.bio/2026/01/luma-h…

🧵 Luma Health Welcomes Michael Chou as SVP of Product to Accelerate Operational AI Development #LumaHealthMichael

1/ read more at talk.bio/2026/01/the-la…

🧵 The Lancet Publishes TRICORDER Study: AI-Enabled Stethoscopes Boost Cardiac Detection in NHS Trial #AiStethoscopeTricorder

1/ read more at talk.bio/2026/01/reperi…

🧵 Reperio Health and Amazon One Medical Partner to Streamline At-Home Preventive Care #AmazonOneMedical

🧵 IRA Medicare Drug Price Negotiation: Round Three Expected in 2028 with Reforms Aimed at Pharma Manageability #IraNegotiationsMedicare

1/ read more at talk.bio/2026/01/29/ira…

🧵 IRA Medicare Drug Price Negotiation: Round Three Expected in 2028 with Reforms Aimed at Pharma Manageability #IraNegotiationsMedicare

1/ read more at talk.bio/2026/01/29/eik…

🧵 Eikon and Veradermics Announce IPO Targets Amid Biotech Market Optimism #EikonTherapeuticsVeradermics